Not provided
Not provided
Not provided
Not provided
Not provided
Limited patient willingness and clinic capacity hindered follow-up data collection for the registry study, as appointments required extra resources beyond routine care.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to collect clinical and radiological mid-term (min. 1 year) data on the ArcadiusXP L® lumbar stand-alone cage in a post-market clinical follow-up study (PMCF) limited to 60 patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arcadius XP L® | all patients who received a Arcadius XP L® interbody fusion device between 2016 until approx. January 2021 (minimum Follow-up is one year) in the study center |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ArcadiusXP L® Interbody Fusion System | Device | The ArcadiusXP L® Interbody Fusion System is a stand-alone device intended to be used with four bone screws if no supplement fixation is used to stabilize the lumbar spine through an anterior approach. Levels of anterior lumbar interbody fusion for the indications listed in the instructions for use are from L2-S1. |
| Measure | Description | Time Frame |
|---|---|---|
| Functional outcome after minimum 1 year postoperatively | The Oswestry Disability Index (ODI) is designed to measure back-specific disability. The questionnaire is self-administered and has 10 items concerning pain and activities of daily living including personal care, lifting, walking, sitting, standing, sleeping, sex life, social life and travelling. It is a self-administered questionnaire Each section is scored on a 0-5 scale, 5 is for maximum disability. The index is calculated by dividing the total score by the total possible score, which is multiplied by 100 and expressed as a percentage. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible. | at follow-up approximately 1 year postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Pain assessment | Pain will be assessed by the patient using the Visual Analogue Scale (VAS) which state "0" at one end representing "no pain" and "100" at the opposite end representing "maximal/worst pain". Pain will be recorded at minimum 12 months postoperatively, if available in the preoperative clinical routine data, it will also be recorded in the study. | at follow-up approximately 1 year postoperatively |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
All patients that received an Arcadius XP L® interbody fusion device in accordance with the indications given in the instructions for use:
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wolfram Reithmeier, Dr. | Schelztor-Klinik | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Schelztor-Klinik Esslingen | Esslingen am Neckar | Baden-Wurttemberg | 73728 | Germany | ||
| Medius Klinik Nürtingen |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D055959 | Intervertebral Disc Degeneration |
| ID | Term |
|---|---|
| D013122 | Spinal Diseases |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Development Quality of life (EQ-5D-5L) | "EQ-5D-5L" is a standardized 5-dimension 5-level measure of the health status and is developed by the EuroQol Group in order to have a simple and generic measure for clinical and economic assessment. In order to analyze the quality of life of the patients, the EQ-5D-5L is used. The score is self-completed by the patient and will therefore be used in German. | at follow-up approximately 1 year postoperatively |
| Radiological Outcome: Bone fusion | After Interbody Fusion surgery fusion of the treated segment is aspired. Thus, the implant design shall allow on-/ingrowth to/into the material. The fusion status can be determined from radiographs (static or dynamic). Bony fusion can be characterized quantitatively by the fusion rate. | at follow-up approximately 1 year postoperatively |
| Rate of (Serious) adverse events | Occurrence of complications potentially associated with the implanted devices can never be fully excluded during spinal surgery. In order to monitor potential complication and to identify so far unknown complications AEs and SAEs deemed related to the investigational device are recorded. | at follow-up approximately 1 year postoperatively |
| Nürtingen |
| Baden-Wurttemberg |
| 72622 |
| Germany |
| Rems-Murr-Klinik Schorndorf | Schorndorf | Baden-Wurttemberg | 73614 | Germany |